Website is intended for physicians
Search:
Всего найдено: 12

authors: 

 

Abstract:

According to current recommendations and orders of the Russian Ministry of Health, in the department of ultrasound diagnostics of the oncological center, it is necessary and lawfully to perform invasive manipulations to obtain a morphological verification of the oncological process. Nevertheless, there are significant gaps in the existing normative acts concerning organizational aspects.

Aim: to conduct an analysis of the organization and results of morphological testing of malignant neoplasms in conditions of separation of ultrasonic diagnostics of the Kursk Regional Clinical Oncology Center.

Materials and methods: 5,114 results of histological and immunohistochemical studies of material obtained with biopsies under ultrasound in the period 2012 - 2016 were analyzed. For the first time we included into department - 2 manipulation rooms, corresponding to sanitary requirements for conducting sterile manipulations. We first install Sonoscape S40 scanners in the manipulation rooms. All invasive examinations were performed by ambulatory and resident patients by ultrasound specialists who have a primary specialization in surgery, gynecology or urology Core biopsy was performed under local anesthesia with semi-automatic needles 14G or 16G; a gun-needle system biopsy was performed using a Bard-Magnum biopsy gun, 18 G needle, and a biopsy attachment to the rectal sensor. The material was preserved in a 10% solution of neutral formalin, labeled and sent to the department of oncomorphology with application of the direction to the intravital pathological anatomical study of the biopsy material. Statistical processing of the data was carried out using the SPSS program «STATISTICS 20.0». Conjugation tables were compiled to determine the relationship between variables. Pearson's x2 was used as the communication criterion, and its asymptomatic two-sided significance was estimated.

Results. During the research, high efficiency of the proposed organizational model is revealed. A statistical relationship is revealed between the informativeness of the material and the physiciar who manipulates and organ-object. Ways of development are offered.

 

References

1.      Kaprin A.D., Starinskij V.V., Petrova G.V. The state of oncological care for the population of Russia in 2013. M.: FGBU «MNIOI im. PA. Gercena» Minzdrava Rossii. 2014; 235 s [In Russ].

2.      Order of the Ministry of Health of the Russian Federation of 04.07.2017 No. 379n «On Amending the Procedure for the provision of medical care to the population in the field of oncology, approved by Order of the Ministry of Health of the Russian Federation of November15, 2012No.915n»].URL.:http://www.consultant.ru/document/cons_doc_LAW_220809/f891655c8c9f6864b656ef 38dba5a212e7e2b0e6/ (Data obrashhenija 23.10.2017) [In Russ].

3.      Chissov V.I., Dar'jalova S.L. [Oncology]. M.: «GJeOTAR-Media». 2007; 560 s [In Russ].

4.      Ponedel'nikova N.V., Korzhenkova G.P, Letjagin VP, Vishnevskaja Ja.V. Choice of the method of verifying the volume of newgrowth of the mammary gland at the preoperative stage. Opuholi zhenskoj reproduktivnoj sistemy. 2011; 1: 41-45 [In Russ].

5.      Nazarenko G.I., Hitrova A.N. Ultrasonic diagnostics of the prostate in modern oncological practice. M.: Izdatel'skij dom Vidar-M. 2012; 288s [In Russ].

6.      About the improvement of the service of radiation diagnosis: the order of the Ministry of Health of the RSFSR of August 2, 1991 № 132. URL.:http:// www.rasudm.org /information/docs.htm (Data obrashhenija 23.10.2017) [In Russ].

7.      Order of the Ministry of Health of the Russian Federation of December 27, 2011 N 1664n "ОП the approval of nomenclature of medical services". URL.:http://www.consultant.ru/cons/cgi/online.cgi?req=doc&base=LAW&n=27 8063&fld=134&dst=1,0&rnd=0.05494875175266367#0 (Data obrashhenija 04.11.2017) [In Russ].

8.      Decree of the Chief State Sanitary Doctor of the Russian Federation of May 18, 2010 No.58 «On approval SanPiN 2.1.3.2630-10» Sanitary and epidemiological requirements for organizations engaged in medical activities «with amendments and additions from: March 4, June

10,    2016. URL.: http://base.garant.ru/12177989/ #ixzz4xU73XzAB (Data obrashhenija 04.11.2017) [In Russ].

9.      Attachment №2 to the order of the Ministry of Health of the Russian Federation of March 24, 2016 N 179n «On the Rules of Pathology and Anatomical Research» (registered by the Ministry of Justice of the Russian Federation on April 14, 2016, registrationN41799). URL.:http://pravo.gov.ru/proxy/ips/?docbody=&nd= 102396069 (Data obrashhenija 04.11.2017) [In Russ].

10.    SPSS: the art of information processing. Analysis of statistical data and restoration of hidden regularities. Ahim Bjujul', Peter Cefel'.- DiaSoft, 2005; 608 s [In Russ].

 

Abstract:

In the article considers modern commercial method of production is demanded used in oncology medical product radiopharmaceutical 18F-fluorodeoxyglucose (2-fluoro,18F-2-deoxy-D-glucose, 18F-FDG), are presented the process steps and operation of synthesis, quality control procedures, briefly described the requirements for packaging and labeling of radiopharmaceutical.

 

 

References

1.     Kam Leung. [18F]Fluoro-2-deoxy-2-D-glucose in Molecular Imaging and Contrast Agent Database (MICAD). National Center for Biotechnology Information, NLM, NIH, Bethesda, MD. 2005.

2.     Min-Fu Yang, Diwakar Jain, Zuo-Xiang He. 18F-FDG Cardiac Studies for Identifying Ischemic Memory. Curr Cardiovasc Imaging Rep. 2012; Dec, 5:383-389.

3.     Ghesani M., Depuey E. G., Rozanski A. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability. Echocardiography. 2005 Feb; 22(2): 165-77.

4.     Nose H., Otsuka H., Otomi Y et al. Evaluation of normal physiologic left ventricular myocardial 18F-FDG uptake at fasting state. European Congress of Radiology. 2012. Vienna, Austria. URL: http://posterng.netkey.at/esr/ viewing/index.php?module=viewing_poster&doi=10.1594 /ecr2012/C-1192 2012.

5.     Dong Soo Lee, Sang Kun Lee, Myung Chul Lee. Functional Neuroimaging in Epilepsy: FDG PET and Ictal SPECT. Korean Med Sci. 2001;16: 689-96.

6.     Teune L. K., Bartels A. L., Leenders K. L. FDG-PET Imaging in Neurodegenerative Brain Diseases // Functional Brain Mapping and the Endeavor to Understand the Working Brain edited by Francesco Signorelli and Domenico Chirchiglia, 2013.

7.     Sanchez-Catasis C. A., Vallez, Garcha D., Le Riverend Morales E., Galvizu Sбnchez R. Traumatic Brain Injury: Nuclear Medicine Neuroimaging .PET and SPECT in Neurology. 2014; 923-946.

8.     Masangkay N., Basu S., Moghbel M. et al. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings. Nucl Med Commun. 2014 Oct; 35 (10): 1038-46.

9.       Statistika zlokachestvennyh novoobrazovanij v Rossii i stranah SNG v 2012 g. Pod redakciej M.I. Davydova, E.M. Aksel'. [Statistics of malignant neoplasms in Russia and CIS countries in 2012. Edited by M.I. Davydova, E.M. Axel.] Moskva, 2014. - 226 s [In Russ].

10.   Jones S. C., Alavi A., Christman D. et al. The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. J Nucl Med. 1982; 23, 613-617.

11.   Kuwabara H., Gjedde A. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate. J Nucl Med. 1991 Apr; 32(4): 692-8.

12.   Data are from International Commission on Radiological Protection. Radiation Dose to Patients from Radiopharmaceuticals. St. Louis, MO. Elsevier; 2000:49. ICRP publication 80.

13.   Ido T., Wan C. N., Fowler J. S. Fluorination with F2: convenient synthesis of 2-deoxy-2-fluoro-d-glucose. J Org Chem. 1977; 42: 2341-2.

14.   Hamacher K., Coenen H. H., Stacklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]- fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986; 27: 235-8.

15.   Toorongian S. A., Mulholland G. K., Jewett D. M. et al. Routine production of 2-deoxy-2-[18F]fluoro-D- glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Int J Rad Appl Instrum B. 1990; 17 (3): 273-9.

16     Normy radiacionnoj bezopasnosti (NRB-99/2009). [Norms of radiation safety (NRB-99/2009).] SP 2.6.1.2523-09.[In Russ].

17.   Osnovnye sanitarnye pravila obespecheniya radiacionnoj bezopasnosti (OSPORB-99/2010). [Basic sanitary rules for ensuring radiation safety (0SP0RB-99/2010)]. SP 2.6.12612-10 [In Russ].

18.   SanPiN 2.6.1.3288-15 «Gigienicheskie trebovaniya po obespecheniyu radiacionnoj bezopasnosti pri podgotovke i provedenii pozitronnoj ehmissionnoj tomografii». [Hygienic requirements for ensuring radiation safety in the preparation and conduct of positron emission tomography.] [ In Russ].

19.   N.A. Gomzina, D.A. Vasil’ev, R.N. Krasikova. Optimization of Automated Synthesis of 2-[18F]Fluoro- 2-deoxy-D-glucose Involving Base Hydrolysis. Radiochemistry. 2002; 44 (4): 403-409.

20.   Gopal B. Saha. Basics of PET Imaging: Physics, Chemistry and Regulations. - 3th ed. - New York: Springer International Publishing, 2016; 165.

Abstract:

Aim: was to estimate the functionality of the nanokoloid drug labeled with technetium-99m for scintigraphy and intraoperative detection of «sentinel» lymph nodes (SLN) in experimental animals.

Materials and methods: the study was performed in 6 series of experiments, including 5 white male rats line «Wistar» weighing 300-350 g. Injection of radiopharmaceuticals (RPh) at a dose of 18-20 MBq were performed between the first and second fingers of the front paws of rats.

Results: in scintigraphic studies STL noted that RPh «Nanocolloid, 99mTc-Al2O3» accumulation reaches a plateau at the node (10.2%) for 2 hour study and its percentage content is stored at this level until 24 h. Intraoperative study, in all cases it was possible to visualize the STL.

Conclusions: results shows functional fitness RPh «Nanocolloids,99mTc-Al2O3» for scintigraphy and intraoperative detection of «sentinel» lymph nodes. 

 

References

1.     Semiglazov V.F. Novoe napravlenie v sberegatel'nom i organosohranjajushhem hirurgicheskom lechenii zlokachestvennyh opuholej. [A new trend in savings and organ-surgical treatment of malignant tumors]. Medicinskij vestnik 2009; 35 (504): 12-24 [In Russ].

2.     Abu-Rustum N.R., Knoury-Collado F., Gemignani M.L. Tehniques of sentinel lymph node identification for early-stage cervical and uterine cancer. Gynecol. Oncol. 2008; 111(2): 44-50.

3.     Altgassen C., Hertel H. et al. Multicenter valida- cion study of the sentinentel lymph node concept in cervical cancer: AGO Study Group. J. Clin. Oncol. 2008; 26: 2943-2951.

4.     Kuznecov V.V., Lebedev A.I., Morhov K.Ju., Gricaj A.N. Hirurgija invazivnogo raka shejki matki [Surgery is invasive cervical cancer]. Prakticheskaja onkologija. 2002; 3(3): 178-182 [In Russ].

5.     Hauspy J., Beiner M., Harley А. Sentinel Lymph Node in early stage cervical cancer. Gynecol. Oncol. 2008; l08 (1): 256-257.

6.     Takeda N., Sakuragi N., Takeda M. et al. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet. Gynecol. Scand. 2002; 81: 1144-1151.

7.     Seong S.J., Park H., Yang K.M. et al. Detection of sentinel lymph nodes in patients with early stage cervical cancer. J. Korean Med. Sci. 2007; 22 (1): 105-109.

8.     Baggish M.S., Karram M.K. Atlas anatomii taza i ginekologicheskoj hirurgii [Atlas of pelvic anatomy and gynecologic surgery]. London: Izd-vo Elsevier Ltd. 2009; 1172 [In Russ].

9.     Lawrenz B., Jauckus J., Kupka M.S. et al. Fertility preservation in >1,000 patients: patient’s characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch. Gynecol. Obstet. 2010; 283(3): 651-656.

10.   Klinicheskaja onkoginekologija: Rukovodstvo dlja vrachej. (Pod red. V.P Kozachenko) [Clinical cancers: A Guide for Physicians. (Ed. V. Kozachenko)]. M.: Medicina, 2005; 431[In Russ].

11.   Abu-Rustum N.R., Neubauer N., Sonoda Y et al. Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer. Gynecol. Oncol. 2008; 111(2): 261-264.

Acardiac fetus: postmortem computed and magnetic resonance tomography imaging



DOI: https://doi.org/10.25512/DIR.2016.10.2.03

For quoting:
Tumanova U.N., Fedoseeva V.K., Lyapin V.M., Bychenko V.G., Voevodin S.M., Shchegolev A.I. "Acardiac fetus: postmortem computed and magnetic resonance tomography imaging". Journal Diagnostic & interventional radiology. 2016; 10(2); 23-30.

 

 

Abstract:

Acardiac fetus («acardiac monster», «acardiac vampire») - is rarely encountered pathology of pregnancy in which one of monochorionic fetuses (recipient) is formless mass, with absence of the heart and some internal organs, life and growth of which is related to parasitism on other fetus.

The main reason for the formation of this defect is an abnormal location of placental vessels ir monochorionic twins. Characteristic are the underdevelopment of the upper body of the recipient fetus (underdevelopment of the upper part of chest, the absence of heart or the presence of rudimentary heart) and acephaly

The article presents results of the analysis of the world literature data, and given own observation of acardiac fetus stillborn.

We specify frequency causes, as well as the clinical and morphological features such anomalies. Possibilities of the post-mortem magnetic resonance and computed tomography imaging in determining the type of acardiac fetus. According to results of the analysis, it was the most efficient construction and analysis of volumetric reconstruction of bone tissues.

Conclusion: post-mortem CT and MRI are advisable in some cases as a complement to the postmortem examination.

 

References

1.     Alderman B. Foetus acardius amorphus. Postgraduate Med. J. 1973; 49: 102-105.

2.     Chi J.G. Acardiac twins. J. Korean. Med. Sci. 1989; 4: 203-216.

3.     Benirschke K. The Monozygotic twinning process, the twin-twin transfusion syndrome and acardiac twins. Placenta. 2009; 3: 923-928.

4.     Obladen M. From monster to twin reversed arterial perfusion: a history of acardiac twins J. Perinat. Med. 2010; 38(3): 247-253.

5.     Dahiya P, Agarwal U, Sangwan K, Sen J. Antenatal diagnosis of twin-reversed arterial perfusion sequence (acardiac amorphous) in a triplet pregnancy: case report. Arch. Gynecol. Obst. 2004; 269: 147-148.

6.     Gillim D.L., Hendriks C.H. Holoacardius: review of the literature and case report. Obstet. Gynecol. 1953; 2: 647-653.

7.     Bhatnagar K.P, SharmaS.C., Bisker J. The holoacardius: a correlative computerized tomographic, radiologic, and ultrasonographic investigation of a new case with review of literature. Acta genet. med. Gemellot. 1986; 35: 77-89.

8.     Shchegolev A.I., Tumanova U.N., Shuvalova M.P., Frolova O.G. Vrozhdennie poroki kak prichina mertvorozhdeniya[Congenital anomalies as a cause stillbirth]. Mezhdunarodnyj zhurnal prikladnyh i fundamental'nyh issledovanij. 2015; 10 (2): 263-267 [In Russ].

9.     Demikova N.S., Lapina A.S. Vrozhdennie poroki razvitiya v regionah Rossiyskoi Federatsii (itogi monitoringa 2000-2010 gg. [Congenital malformations in regions of the Russian Federation (monitoring results for 2000-2010]. Rossijskij vestnik perinatologii i pediatrii. 2012; 2: 91-98 [In Russ].

10.   Fox H, Butler-Manuel R. A teratoma of the placenta. J. Pathol. Bacteriol. 1964; 88: 137-140.

11.   Thayyil1 S., Chitty L.S., Robertson N.J. et al. Minimally invasive fetal postmortem examination using magnetic resonance imaging and computerised tomography: current evidence and practical issues. Prenat. Diagn. 2010; 30: 713-718.

12.  Tumanova U.N., Fedoseeva V.K., Liapin V.M., Stepanov A.V., Voevodin S.M., Shchegolev A.I. Posmertnaya kompjuternaya tomographia mertvorozhdennikh s kostnoi patologiej [Computed Tomography of Stillborn with Bone Pathology]. Meditsinskaya vizualizatsiya. 2013; 5, 110-120 [In Russ].

13.  Fedoseeva V.K., Tumanova U.N., Liapin V.M. Voevodin S.M., Shchegolev A.I. Vozmozhnosti ispolzovaniya multispiralnoj kompjuternoi tomografii v posmertnoi diagnostike patologii plodov i novorozhdennikh. [Possibilities of use of a multispiral computer tomography in posthumous diagnosis of pathology of fetus and newborns]. REJR. 2014; 3 (S2): 448 [In Russ].

14.   Aghayev E., Staub L., Dirnhofer R., et al. Virtopsy - the concept of a centralized database in forensic medicine for analysis and comparison of radiological and autopsy data. J. Forensic. Leg. Med. 2008; 15: 135-140.

15.  Kokov L.S., Kinle A.F., Sinitsyn V.Y., Filimonov B.A. Voz- mozhnosti kompyuternoj i magnitno rezonansnoj tomografii v sudebno medicinskoj ehkspertize mekhanicheskoj travmy i skoropostizhnoj smerti obzor literatury. [Possibilities of computed tomography and magnetic resonance imaging in forensic medicalexamination of mechanical trauma and sudden death (a literature review)]. Zhwrnalim. N.V. Sklifosovskogo. Neotlozhnaya meditsinskaya pomoshch. 2015; 2: 16-26 [In Russ].

16.   Moore T.R., Gale S., Benirschke K. Perinatal outcome of forty nine pregnancies complicated by acardiac twinning. Am. J. Obstet. Gynecol 1990; 163: 907-912.

17.   Blickstein I., Keith G.L. Multiple pregnancy. Informa healthcare. 2005.

18.   Coulam С.В., Wright С. First trimester diagnosis of асаrdiас twins. Еагу Ргеgnаnсу 2000; 4: 261-270.

19.   Larsen W.J. Development of the heart. Human embryology. 2nd ed. Churchill Livingstone. 1997; 151-187.

20.   Baergen N.R. Manual of Pathology of the human placenta. 2nd ed. Springer Science+Business Media: LLC, 2011.

21.   Kamitomo М., Kouno S., Ibuka К. et al. First-trimester findings associated with twin reversed arterial perfusion sequence. Fetal Diagn. Ther. 2004; 19: 187-190.

22.  Ajlamazjan E.K., Pavlova N.G., Shelaeva E.V., Bezhenar V.F. Sindrom obratnoj arterialnoj perfuzii pri mnogoplodii obzor literatury i sobstvennyj opyt diagnostiki i fetalnoj hirurgii. [Syndrome of the return arterial perfusion at a mnogoplodiya: review of literature and own experience of diagnostics and fetalny surgery]. Prenat. diagn. 2012; 2: 178-184 [In Russ].

23.   Al-Malt А., Ashmead G., Judge N. et al. Color-ftow and Doppler velocimetry in prenatal diagnosis of acardiac triples. J. Ultrasound Med. 1991; 10: 341-345.

24.   Izquierdо I., Smith J., Gilson G. еt al. Twin, acardiac, acephalus. Fetus. 1992; 1: 1.

25.   Papa Т., Dao А., Bruner J.P Pathognomonic sign of twin reversed arterial perfusion using color Doppler sonography. J. Ultгаsоund Med. 1997; 16: 501-503.

26.   Sabourin J., DeDoming E., Chandra S., Jain V. Twin reversed arterial perfusion syndrome. J. Obstet. Gynaecol. Can. 2011; 33: 315.

27.   Mccurdy C.M., Childers J.M., Seeds J.W. Ligation of the umbilical cord of an acardiac-acephalous twin with an endoscopic intrauterine technique. Obstet. Gynecol. 1993; 82: S708-S711.

28.   Corbacioglu A., Gul A., Bakirci I.T. et al. Treatment of twin reversed arterial perfusion sequence with alcohol ablation or bipolar cord coagulation. Int. J. Gynaecol. Obstet. 2012; 117: 257-259.

29.   Weichert A., Kalache K., Hein P. et al. Radiofrequency ablation as a minimally invasive procedure in the treatment of twin reversed arterial perfusion sequence in twin pregnancy. J. Clin. Ultrasound. 2012; May 10. doi: 10.1002/jcu.21932.

30.   Tan T.YT., Sepulveda W. Acardiac twin: A systematic review of minimally invasive treatment modalities. Ultrasound Obstet. Gynecol. 2003; 22: 409-419.

31.   Sepulveda W., Sfeir D., Reyes M., Martinez J. Severe polyhydramnios in twin reversed arterial perfusion sequence: successful management with intrafetal alcohol ablation of acardiac twin and amniodrainage. Ultrasound Obstet. Gynecol. 2000; 16: 260-263.

 

 

ANGIOLOGIA.ru (АНГИОЛОГИЯ.ру) - портал о диагностике и лечении заболеваний сосудистой системы